Results 151 to 160 of about 71,434 (250)

2-Hydroxyisoquinoline-1,3(2H, 4H)diones (HQDs), novel inhibitors of the HIV integrase catalytic activity with a high barrier to resistance [PDF]

, 2013
Frauke Christ, Jonas Demeulemeester, Belete A. Desimmie, Virginie Suchaud, Oliver Taltynov, Cédric Lion, Fabrice Bailly, Sergei V. Strelkov, Philipe Cotelle, Zeger Debyser   +9 more
openalex   +1 more source

Study of a new class of HIV-1 reverse transcriptase and integrase inhibitors.

, 2005
J. Didierjean
openalex   +1 more source

Impact of the HIV integrase genetic context on the phenotypic expression and in vivo dynamics of integrase inhibitor resistance mutations [PDF]

, 2013
Nga Thi Thuy Nguyen, Sylvie Rato, François Clavel, Constance Delaugerre, Fabrizio Mammano   +4 more
openalex   +1 more source

Retrointegration2023-Papers from the 7th International Conference on Retroviral Integration. [PDF]

Viruses
Engelman AN, Grandgenett DP, Maertens GN, Yoder KE, Kvaratskhelia M.   +4 more
europepmc   +1 more source

Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients

, 2011
Isabelle Malet, Marc Wirden, Slim Fourati, Daniele Armenia, Bernard Masquelier, Lavinia Fabeni, Sophie Sayon, Christine Katlama, Carlo Federico Perno, Vincent Cálvez, Anne‐Geneviève Marcelin, Francesca Ceccherini‐Silberstein   +11 more
openalex   +1 more source

Investigation of furo[2,3-h]- and pyridazino[3,4-f]cinnolin-3-ol scaffolds as substrates for the development of novel HIV-1 integrase inhibitors

, 2011
Mohamed F. Y. Gomaa, Nicolino Pala, Marco Derudas, Jehan Abd-Elrazik Hasanen, Elsayed H. Eltamany, Paola Casule, Alberto Mariani, Mario Sechi   +7 more
openalex   +2 more sources

Lack of Resistance to Integrase Inhibitors among Antiretroviral-Naive Subjects with Primary HIV-1 Infection, 2007–2013 [PDF]

, 2014
Joanne D. Stekler, Jennifer L. McKernan, Ross Milne, Kenneth Tapia, Kateryna Mykhalchenko, Sarah Holte, Janine Maenza, Claire E. Stevens, Susan E. Buskin, James I. Mullins, Lisa M. Frenkel, Ann C. Collier   +11 more
openalex   +1 more source

Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes

, 2011
Kendra E. Hightower, Ruolan Wang, Felix Deanda, Brian A. Johns, Kurt Weaver, Yingnian Shen, Ginger H. Tomberlin, H. Luke Carter, Timothy M Broderick, Sigethy Scott, Takahiro Seki, Masanori Kobayashi, Mark Underwood   +12 more
openalex   +1 more source

Pharmacological advances in HIV treatment: from ART to long-acting injectable therapies. [PDF]

Arch Virol
Łupina K, Nowak K, Lorek D, Nowak A, Romac A, Głowacka E, Janczura J.   +6 more
europepmc   +1 more source

Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in France [PDF]

, 2014
Nicolas Despiégel, Anne-Geneviève Marcellin, C. Aubin, Caroline Espinas, Audrey Laurisse, Gilles Pialoux   +5 more
openalex   +1 more source